Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity
BL Erstad, JF Barletta - Annals of Pharmacotherapy, 2023 - journals.sagepub.com
Objective: The objective of the study was to discuss the controversies surrounding the use
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …
[HTML][HTML] Characterization of Antithrombotic Regimens for Patients with Nonvalvular Atrial Fibrillation and Obesity Discharged from Cardiology Wards
S O'Byrne, K Tangedal, B Kennedy… - Canadian Journal of …, 2024 - cjhp-online.ca
Background: Despite data derived from observational studies, optimal anticoagulation
strategies have yet to be established for patients with nonvalvular atrial fibrillation and …
strategies have yet to be established for patients with nonvalvular atrial fibrillation and …
PERBANDINGAN EFEKTIVITAS RIVAROXABAN DAN WARFARIN DALAM MENGATASI KEJADIAN EMBOLI PADA PASIEN DENGAN ATRIAL FIBRILASI
FD Tamara - Jurnal Ners, 2023 - journal.universitaspahlawan.ac.id
Atrial Fibrilasi (AF) merupakan salah satu jenis aritmia jantung paling umum yang
disebabkan oleh aktivitas listrik abnormal di atrium jantung. Sebuah studi yang dilakukan di …
disebabkan oleh aktivitas listrik abnormal di atrium jantung. Sebuah studi yang dilakukan di …